Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

DSM-Firmenich AG (ZX6.F)

Compare
90.18
+0.26
+(0.29%)
At close: April 17 at 3:29:01 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Dimitri de Vreeze Chief Executive Officer 4.34M -- 1967
Mr. Ralf Schmeitz Chief Financial Officer -- -- 1973
Mr. Emmanuel Butstraen BU President of Perfumery & Beauty and COO -- -- 1968
Dr. Sarah Reisinger Chief Science & Research Officer -- -- 1979
Mr. Dave Huizing Vice President of Investor Relations -- -- --
Ms. Jane Sinclair Chief Legal, Risk & Compliance Officer -- -- 1962
Ms. Lieke de Jong-Tops Senior Communications Manager -- -- --
Ms. Mieke Van de Capelle Chief Human Resources Officer -- -- 1974
Mr. Luca Rosetto Senior Vice President of Operations - Nutritional Products -- -- 1963
Mr. Philip Eykerman BU President of Health Nutrition & Care -- -- 1969

DSM-Firmenich AG

Wurmisweg 576
Kaiseraugst, 4303
Switzerland
41 61 815 17 26 https://www.dsm-firmenich.com
Full Time Employees: 
26,301

Description

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Corporate Governance

DSM-Firmenich AG’s ISS Governance QualityScore as of April 1, 2025 is 3. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 6:00 AM UTC

DSM-Firmenich AG Earnings Date

May 8, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

December 14, 2023 at 12:00 AM UTC

F-6: Offering Registrations

October 14, 2022 at 12:00 AM UTC

F-6 POS: Offering Registrations

Related Tickers